The agency has signaled broader interest in ensuring that companies operating in the health‑tech ecosystem maintain transparent data policies and do not engage in conduct that could disadvantage patients or healthcare providers.
The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
OpenAI provided the first detailed explanation of the Hugging Face incident at the annual cybersecurity conference in Las Vegas.
Overview of EU AI Act transparency obligations under Art 50, and guidance for legal and compliance counsel.
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Changes in the surveillance function were the focus of one discussion at XLOD Global.
Our regular look at notable regulatory and compliance developments in the region.
This panel discussion at XLOD Global 2026 focused on how regulatory pressure has moved the dial on resilience.
